Juan Carlos Rejón-Parrilla

The Future of Precision Medicine: Potential Impacts for Health Technology Assessment

James Love-Koh, Alison J. Peel, Juan Carlos Rejón-Parrilla et al. · PharmacoEconomics · 2018 · 131 citations · Full text

Public Affairs, Health Policy, Clinical Medicine +5

What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the development of the EQ-HWB?

Tessa Peasgood, Clara Mukuria, Jill Carlton et al. · The European Journal of Health Economics · 2021 · 44 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16

Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices)

Alan G. Fraser, Rob G. H. H. Nelissen, Per Kjærsgaard‐Andersen et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 2021 · 33 citations · Full text

Law, Health Policy, Pharmaceutical Policy +17

The use of nonrandomized evidence to estimate treatment effects in health technology assessment

Seamus Kent, Maximilian Salcher‐Konrad, Stefania Boccia et al. · Journal of Comparative Effectiveness Research · 2021 · 29 citations · Full text

Public Affairs, Health Policy, Pharmacoeconomics +17

Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries

Juan Carlos Rejón-Parrilla, Jaime Espín, Sarah Garner et al. · Frontiers in Pharmacology · 2023 · 26 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +16